Literature DB >> 11488295

Multiple sclerosis: more than inflammation and demyelination.

P Rieckmann1, K J Smith.   

Abstract

Entities:  

Mesh：

Year:  2001        PMID： 11488295     DOI： 10.1016/s0166-2236(00)01860-9

Source DB:  PubMed          Journal:  Trends Neurosci        ISSN： 0166-2236            Impact factor:   13.837


× No keyword cloud information.
  9 in total

Review 1.  Recombinant T cell receptor ligands: immunomodulatory, neuroprotective and neuroregenerative effects suggest application as therapy for multiple sclerosis.

Authors:  Halina Offner; Sushmita Sinha; Chunhe Wang; Gregory G Burrows; Arthur A Vandenbark
Journal:  Rev Neurosci       Date:  2008       Impact factor: 4.353

2.  Cognitive deficit associated with cholinergic and nerve growth factor down-regulation in experimental allergic encephalomyelitis in rats.

Authors:  Giulia D'Intino; Michela Paradisi; Mercedes Fernandez; Alessandro Giuliani; Luigi Aloe; Luciana Giardino; Laura Calzà
Journal:  Proc Natl Acad Sci U S A       Date:  2005-02-14       Impact factor: 11.205

3.  Antigen-specific therapy promotes repair of myelin and axonal damage in established EAE.

Authors:  Chunhe Wang; Bruce G Gold; Laurie J Kaler; Xiaolin Yu; Michael E Afentoulis; Gregory G Burrows; Arthur A Vandenbark; Dennis N Bourdette; Halina Offner
Journal:  J Neurochem       Date:  2006-08-03       Impact factor: 5.372

4.  Tyrphostin A9 protects axons in experimental autoimmune encephalomyelitis through activation of ERKs.

Authors:  Xiaodong Dai; Yongmei Wang; Yuexin Li; Yongping Zhong; Min Pei; Jing Long; Xingchen Dong; Yi-Li Chen; Qi Wang; Guifeng Wang; Bruce G Gold; Arthur A Vandenbark; Kim A Neve; Halina Offner; Chunhe Wang
Journal:  Life Sci       Date:  2022-02-07       Impact factor: 5.037

Review 5.  Biosynthesis of endocannabinoids and their modes of action in neurodegenerative diseases.

Authors:  Mario van der Stelt; Henrik H Hansen; Wouter B Veldhuis; Peter R Bär; Klaas Nicolay; Gerrit A Veldink; Johannes F G Vliegenthart; Harald S Hansen
Journal:  Neurotox Res       Date:  2003       Impact factor: 3.911

6.  A type 2 biomarker separates relapsing-remitting from secondary progressive multiple sclerosis.

Authors:  Alex M Dickens; James R Larkin; Julian L Griffin; Ana Cavey; Lucy Matthews; Martin R Turner; Gordon K Wilcock; Benjamin G Davis; Timothy D W Claridge; Jacqueline Palace; Daniel C Anthony; Nicola R Sibson
Journal:  Neurology       Date:  2014-09-24       Impact factor: 9.910

7.  Galectin-8 as an immunosuppressor in experimental autoimmune encephalomyelitis and a target of human early prognostic antibodies in multiple sclerosis.

Authors:  Evelyn Pardo; Claudia Cárcamo; Reinaldo Uribe-San Martín; Ethel Ciampi; Fabián Segovia-Miranda; Cristobal Curkovic-Peña; Fabián Montecino; Christopher Holmes; Juan Enrique Tichauer; Eric Acuña; Francisco Osorio-Barrios; Marjorie Castro; Priscilla Cortes; Claudia Oyanadel; David M Valenzuela; Rodrigo Pacheco; Rodrigo Naves; Andrea Soza; Alfonso González
Journal:  PLoS One       Date:  2017-06-26       Impact factor: 3.240

8.  Human periodontal ligament stem cells secretome from multiple sclerosis patients suppresses NALP3 inflammasome activation in experimental autoimmune encephalomyelitis.

Authors:  Thangavelu Soundara Rajan; Sabrina Giacoppo; Francesca Diomede; Placido Bramanti; Oriana Trubiani; Emanuela Mazzon
Journal:  Int J Immunopathol Pharmacol       Date:  2017-08-02       Impact factor: 3.219

9.  Spinal motoneurone distress during experimental allergic encephalomyelitis.

Authors:  L Giardino; A Giuliani; M Fernandez; L Calzà
Journal:  Neuropathol Appl Neurobiol       Date:  2004-10       Impact factor: 8.090
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.